Tomas Kovarnik

Dr. Tomas Kovarnik

orcid

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2014 in Computerized Medical Imaging and Graphics
Verified
Journal Article
Open access
SBSimone Balocco
Simone Balocco
CGCarlo Gatta
Carlo Gatta
FCFrancesco Ciompi
Francesco Ciompi
AWAndreas Wahle
Andreas Wahle
PRPetia Radeva
Petia Radeva
Ioannis A KakadiarisIoannis A Kakadiaris
Ioannis A Kakadiaris
This paper describes an evaluation framework that allows a standardized and quantitative comparison of IVUS lumen and media segmentation algorithms. This framework has been introduced at the MICCAI 2011 Computing and Visualization for (Intra)Vascular Imaging (CVII) workshop, comparing the results of eight teams that participated. We describe the available data-base comprising of multi-center, multi-vendor and multi-frequency IVUS datasets, their acquisition, the creation of the reference standard and the evaluation measures. The approaches address segmentation of the lumen, the media, or both borders; semi- or fully-automatic operation; and 2-D vs. 3-D methodology. Three performance measures for quantitative analysis have been proposed. The results of the evaluation indicate that segmentation of the vessel lumen and media is possible with an accuracy that is comparable to manual annotation when semi-automatic methods are used, as well as encouraging results can be obtained also in case of fully-automatic segmentation. The analysis performed in this paper also highlights the challenges in IVUS segmentation that remains to be solved.

16 March 2012 in Critical Care
Verified
Journal Article
Open access
PDF file
JBJan Belohlavek
Jan Belohlavek
MMMikuláš Mlček
Mikuláš Mlček
MHMichal Huptych
Michal Huptych
TSTomáš Svoboda
Tomáš Svoboda
SHStepan Havranek
Stepan Havranek
OKOtomar Kittnar
Otomar Kittnar
Introduction: Extracorporeal membrane oxygenation (ECMO) is increasingly used in cardiac arrest (CA). Adequacy of carotid and coronary blood flows (CaBF, CoBF) and coronary perfusion pressure (CoPP) in ECMO treated CA is not well established. This study compares femoro-femoral (FF) to femoro-subclavian (FS) ECMO and intraaortic balloon counterpulsation (IABP) contribution based on CaBF, CoBF, CoPP, myocardial and brain oxygenation in experimental CA managed by ECMO. Methods: In 11 female pigs (50.3 ± 3.4 kg), CA was randomly treated by FF versus FS ECMO ± IABP. Animals under general anesthesia had undergone 15 minutes of ventricular fibrillation (VF) with ECMO flow of 5 to 10 mL/kg/min simulating low-flow CA followed by continued VF with ECMO flow of 100 mL/kg/min. CaBF and CoBF were measured by a Doppler flow wire, cerebral and peripheral oxygenation by near infrared spectroscopy. CoPP, myocardial oxygen metabolism and resuscitability were determined. Results: CaBF reached values > 80% of baseline in all regimens. CoBF > 80% was reached only by the FF ECMO, 90.0% (66.1, 98.6). Addition of IABP to FF ECMO decreased CoBF to 60.7% (55.1, 86.2) of baseline, P = 0.004. FS ECMO produced 70.0% (49.1, 113.2) of baseline CoBF, significantly lower than FF, P = 0.039. Addition of IABP to FS did not change the CoBF; however, it provided significantly higher flow, 76.7% (71.9, 111.2) of baseline, compared to FF + IABP, P = 0.026. Both brain and peripheral regional oxygen saturations decreased after induction of CA to 23% (15.0, 32.3) and 34% (23.5, 34.0), respectively, and normalized after ECMO institution. For brain saturations, all regimens reached values exceeding 80% of baseline, none of the comparisons between respective treatment approaches differed significantly. After a decline to 15 mmHg (9.5, 20.8) during CA, CoPP gradually rose with time to 68 mmHg (43.3, 84.0), P = 0 .003, with best recovery on FF ECMO. Resuscitability of the animals was high, both 5 and 60 minutes return of spontaneous circulation occured in eight animals (73%). Conclusions: In a pig model of CA, both FF and FS ECMO assure adequate brain perfusion and oxygenation. FF ECMO offers better CoBF than FS ECMO. Addition of IABP to FF ECMO worsens CoBF. FF ECMO, more than FS ECMO, increases CoPP over time.

15 November 2007 in Acta Anaesthesiologica Scandinavica
Verified
Journal Article
Closed access
PDF file
RSR. Skulec
R. Skulec
TKTomas Kovarnik
Tomas Kovarnik
GDG. Dostalova
G. Dostalova
JKJ. Kolar
J. Kolar
ALAleš Linhart
Aleš Linhart

1 May 2017 in European Journal of Heart Failure
Verified
Journal Article
Closed access
PDF file
DRDaniel Rob
Daniel Rob
RŠRudolf Špunda
Rudolf Špunda
JLJarosla Lindner
Jarosla Lindner
VRVilém Rohn
Vilém Rohn
JKJan Kunstýř
Jan Kunstýř
JBJan Belohlavek
Jan Belohlavek

1 January 2012 in Circulation Journal
Verified
Journal Article
Closed access
TKTomas Kovarnik
Tomas Kovarnik
GMGary S. Mintz
Gary S. Mintz
HSHana Skalicka
Hana Skalicka
AKAles Kral
Ales Kral
JHJan Horak
Jan Horak
ALAleš Linhart
Aleš Linhart
There is no study focusing on changes in coronary atherosclerosis during dual lipid-lowering therapy with statin and ezetimibe. Eighty-nine patients with stable angina randomized in a 1:1 ratio to Group A (aggressive therapy: atorvastatin 80mg, ezetimibe 10mg) and Group S (standard therapy) were analyzed. Treatment period was 12 months. Coronary arteries were examined by intravascular ultrasound and virtual histology. We found a decrease in the percent atheroma volume (PAV) (-0.4%) in Group A compared with an increase (+1.4%) in Group S (P=0.014) and this was accompanied by an increased frequency of combined atherosclerosis regression (increased lumen volume+decreased PAV) in group A (40.5%) compared with group S (14.9%) (P=0.007). The target low-density lipoprotein cholesterol level <2mmol/L, presence of at least 4 of 5 atherosclerotic risk factors, and decreased level of vascular cellular adhesive molecule were independent predictors of plaque regression. There were no significant differences in plaque composition between the 2 groups over the study duration. However, during analysis of the 2 groups together, fibrous and fibro-fatty tissues decreased and dense calcification and necrotic core increased during follow-up. Dual lipid-lowering therapy starts atherosclerosis regression, but does not lead to significant changes in plaque composition. The continuous shift in plaque from fibro and fibro-fatty to necrotic with calcification was present in both groups.

1 January 2017 in American Heart Journal
Verified
Journal Article
Closed access
POPavel Osmancik
Pavel Osmancik
PTPetr Tousek
Petr Tousek
DHDalibor Herman
Dalibor Herman
PNPetr Neuzil
Petr Neuzil
PHPavel Hala
Pavel Hala
PWPetr Widimsky
Petr Widimsky